Early Imaging Can Identify Positive Immunotherapy Responders in Advanced Melanoma – AJMC.com Managed Markets Network
|
Early Imaging Can Identify Positive Immunotherapy Responders in Advanced Melanoma
AJMC.com Managed Markets Network Combining positron emission tomography and computed tomography early in the treatment plan for patients diagnosed with advanced melanoma can help identify the potential benefit of a specific immunotherapy and avoid the risk of non-beneficial … |
